Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Corral de la Fuente, Elena
243  Ergebnisse:
Personensuche X
?
1

MYC targeting by OMO-103 in solid tumors: a phase 1 trial:

Garralda, Elena ; Beaulieu, Marie-Eve ; Moreno, Víctor...
Nature Medicine.  30 (2024)  3 - p. 762-771 , 2024
Link: https://doi.org/10.1038/..
 
?
2

Phase 1 first-in-human dose-escalation study of ANV419 in p..:

Joerger, Markus ; Calvo, Emiliano ; Laubli, Heinz...
Journal for ImmunoTherapy of Cancer.  11 (2023)  11 - p. e007784 , 2023
Link: https://doi.org/10.1136/..
 
?
3

Targeting KRAS in Non-Small Cell Lung Cancer:

Corral de la Fuente, Elena ; Olmedo Garcia, Maria Eugenia ; Gomez Rueda, Ana..
Frontiers in Oncology.  11 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
4

Response to Mobocertinib in a patient with advanced Non-Sma..:

Corral de la Fuente, Elena ; Olmedo García, María Eugenia ; Orejana Martín, Inmaculada...
Current Problems in Cancer: Case Reports.  5 (2022)  - p. 100145 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Prolonged Responses With Trastuzumab Emtasine Treatment of ..:

Martin Huertas, Roberto ; Fernández Abad, María ; Corral de la Fuente, Elena..
Clinical Breast Cancer.  21 (2021)  5 - p. 391-398 , 2021
Link: https://doi.org/10.1016/..
 
?
6

ALK rearranged non–small cell lung carcinoma with EML4-NTRK..:

Corral de la Fuente, Elena ; Benito Berlinches, Amparo ; Gomez Rueda, Ana...
Current Problems in Cancer: Case Reports.  4 (2021)  - p. 100124 , 2021
Link: https://doi.org/10.1016/..
 
?
7

Early relapse of inflammatory breast carcinoma treated with..:

Martin Huertas, Roberto ; Fernández Abad, María ; Corral de la Fuente, Elena..
The Breast Journal.  26 (2019)  4 - p. 800-802 , 2019
Link: https://doi.org/10.1111/..
 
?
8

Prognostic Value of Circulating Endothelial Cells in Gliobl..:

Vaz Salgado, María Angeles ; Earl, Julie ; Berrocal, Victor Rodriguez...
Future Science OA.  8 (2022)  5 - p. , 2022
Link: https://doi.org/10.2144/..
 
?
9

Analysis of adverse drug events as a way to improve cancer ..:

Vicente-Oliveros, Noelia ; Gramage-Caro, Teresa ; Corral de la Fuente, Elena..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10800239/.  , 2024
Link: http://www.ncbi.nlm.nih...
 
?
10

Targeting KRAS in Non-Small Cell Lung Cancer:

Corral de la Fuente, Elena ; Olmedo Garcia, Maria Eugenia ; Gomez Rueda, Ana..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784727/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
11

Early relapse of inflammatory breast carcinoma treated with..:

Martin Huertas, Roberto ; Fernández Abad, María ; Corral de la Fuente, Elena..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216947/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
12

Response to Mobocertinib in a patient with advanced Non-Sma..:

Elena Corral de la Fuente ; María Eugenia Olmedo García ; Inmaculada Orejana Martín...
http://www.sciencedirect.com/science/article/pii/S2666621922000096.  , 2022
Link: https://doi.org/10.1016/..
 
?
13

Targeting KRAS in Non-Small Cell Lung Cancer:

Elena Corral de la Fuente ; Maria Eugenia Olmedo Garcia ; Ana Gomez Rueda..
https://www.frontiersin.org/articles/10.3389/fonc.2021.792635/full.  , 2022
Link: https://doi.org/10.3389/..
 
?
14

Prognostic value of circulating endothelial cells in gliobl..:

María Angeles Vaz Salgado ; Julie Earl ; Victor Rodriguez Berrocal...
https://www.future-science.com/doi/10.2144/fsoa-2022-0008.  , 2022
Link: https://doi.org/10.2144/..
 
?
15

ALK rearranged non–small cell lung carcinoma with EML4-NTRK..:

Elena Corral de la Fuente ; Amparo Benito Berlinches ; Ana Gomez Rueda...
http://www.sciencedirect.com/science/article/pii/S2666621921000727.  , 2021
Link: https://doi.org/10.1016/..
 
1-15